Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2018 Nov 16;157(2):730–740.e11. doi: 10.1016/j.jtcvs.2018.11.022

Table 3:

Peri-operative outcomes

Outcome Non-Heterotaxy CHD Heterotaxy Unadjusted OR Unadjusted p-value Adjusted OR Adjusted p-value
Infection during HT admission 294/974 (30%) 57/145 (49%) 1.50 [1.04–2.15] 0.030 1.54 [1.06–2.25]* 0.015*
Cardiac Reoperation 97/979 (10%) 27/143 (19%) 2.12 [1.32, 3.38] 0.002 1.91 [1.17–3.11] † 0.010
Post-HT Renal Failure Requiring Dialysis 77/1253 (6%) 23/186 (12%) 2.16 [1.32, 3.53] 0.002 2.58[1.51–4.42] 0.001
Mechanically Ventilated > 1 week 429/1202 (36%) 78/177 (44%) 1.42 [1.3–1.95] 0.032 1.70 [1.20–2.40] § 0.003§
Rejection during HT admission 187/1124 (17%) 29/137 (17%) 1.02 [0.67,1.57] 0.916 -- --

Source: SRTR database; CHD: Congenital heart disease; HT: Heart transplant; OPO: Organ Procurement Organization;

Data displayed as n(%), Odds ratio [95% CI]

*

Infection during HT admission adjusted for: Year, pre-HT ECMO pre-HT, Mechanical Ventilation (MV) pre-HT, home location at HT, positive DSXM, history of prior univentricular CHD repair

Cardiac reoperation adjusted for: patient race, VAD and MV pre-HT

Post-HT Renal Failure Requiring Dialysis failure adjusted for: Pre-HT dialysis, eGFR <40 mL/min/1.73 m2, ischemic time>3.5hours, ECMO, ICU location at HT, female race

§

Mechanical Ventilation >1 week adjusted for: MV pre-HT, pre-HT ECMO, Age